Smoking
Impact of dietary factors on cancer screening in Japan examined
Published in Clinical Oncology Week, April 4th, 2005
"Evaluation of cancer screening using case-control studies is less valid in comparison to randomized controlled trials, due to the intrusion of a possible self-selection bias in the former. The randomized controlled trial approach, however, may be difficult in developed countries where mass cancer screening programs are already being performed nationally. Accordingly, case-control studies are often performed instead of randomized controlled trials," reported K.J. Suzuki and colleagues of Hirosaki University.
"In case-control studies, no reports could...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Carcinogenesis
Multistage theory of carcinogenesis refined - Head and Neck Cancer
Dendritic cells mature in presence of tumor cells from head and neck cancer - Melanoma Vaccine
Melanoma-associated antigen mimotope inhibits melanoma cell growth - Oncology
Bone-specific metastatic phenotypes identified as clinically relevant - Acute Leukemia
Liposomal amphotericin B safe and effective for fungal infection treatment - Acute Myeloid Leukemia
Gemtuzumab ozogamicin suitable for first-line therapy in elderly patients - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
